Skip to Content

H23 (Minocycline Hydrochloride Extended-Release 135 mg)

Pill with imprint H23 is Brown, Elliptical / Oval and has been identified as Minocycline Hydrochloride Extended-Release 135 mg. It is supplied by Global Pharmaceuticals.

Minocycline is used in the treatment of bacterial infection; acne; bartonellosis; actinomycosis; rosacea (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for H23

Minocycline hydrochloride extended-release 135 mg H23

Minocycline Hydrochloride Extended-Release

Imprint:
H23
Strength:
135 mg
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Tetracyclines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Global Pharmaceuticals
National Drug Code (NDC):
00115-1247

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide